These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2950752)

  • 1. Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma.
    Shepard KV; Levin B; Faintuch J; Doria MI; DuBrow RA; Riddell RH
    Am J Clin Oncol; 1987 Feb; 10(1):36-40. PubMed ID: 2950752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.
    Shepard KV; Levin B; Karl RC; Faintuch J; DuBrow RA; Hagle M; Cooper RM; Beschorner J; Stablein D
    J Clin Oncol; 1985 Feb; 3(2):161-9. PubMed ID: 3155793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
    Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional chemotherapy of colorectal cancer metastatic to the liver.
    Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E
    Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
    J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM; Byfield JE; Goldfarb PB; Frankel S; Ginn C; Greer S
    Cancer; 1982 Sep; 50(5):850-62. PubMed ID: 6212114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.
    Oberfield RA; McCaffrey JA; Polio J; Clouse ME; Hamilton T
    Cancer; 1979 Aug; 44(2):414-23. PubMed ID: 157798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
    Hohn D; Melnick J; Stagg R; Altman D; Friedman M; Ignoffo R; Ferrell L; Lewis B
    J Clin Oncol; 1985 Jan; 3(1):98-102. PubMed ID: 3155548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.
    Balch CM; Urist MM; Soong SJ; McGregor M
    Ann Surg; 1983 Nov; 198(5):567-73. PubMed ID: 6227295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats.
    Zeng ZS; Zhang ZF; Sigurdson ER
    Surg Oncol; 1995 Jun; 4(3):147-55. PubMed ID: 7582187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR.
    Doria MI; Shepard KV; Levin B; Riddell RH
    Cancer; 1986 Aug; 58(4):855-61. PubMed ID: 2941140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward".
    Friedman MA
    Gan To Kagaku Ryoho; 1983 May; 10(5):1209-24. PubMed ID: 6307163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
    Cohen AM; Schaeffer N; Higgins J
    Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
    Sigurdson ER; Ridge JA; Daly JM
    Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump.
    Peretz T; Freund HR; Isacson R; Ben-Yosef A; Goldin E; Haskel L; Chisin R; Biran S; Durst AL
    Isr J Med Sci; 1988; 24(9-10):562-7. PubMed ID: 2849596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
    Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
    Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.